Australia markets close in 7 minutes

Intellia Therapeutics, Inc. (NTLA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
24.15-0.65 (-2.62%)
At close: 04:00PM EDT
24.40 +0.25 (+1.04%)
After hours: 06:52PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts24242525
Avg. Estimate-1.23-1.36-5.15-5.45
Low estimate-1.44-1.57-5.9-6.87
High estimate-0.98-1.05-4.52-4.09
Year ago EPS-1.4-1.38-5.42-5.15
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts20202725
Avg. Estimate19.16M10.84M70.78M67.89M
Low estimate3.75MN/A40MN/A
High estimate43M33M131M210M
Year ago sales12.08MN/A36.27M70.78M
Sales growth (year/est)58.60%N/A95.10%-4.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.32-1.5-1.45-1.38
Actual EPS-1.4-1.38-1.46-1.12
Difference-0.080.12-0.010.26
Surprise %-6.10%8.00%-0.70%18.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.23-1.36-5.15-5.45
7 days ago-1.23-1.36-5.15-5.45
30 days ago-1.23-1.36-5.14-5.49
60 days ago-1.29-1.42-5.61-5.49
90 days ago-1.29-1.42-5.61-5.49
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNTLAIndustrySector(s)S&P 500
Current qtr.12.10%N/AN/AN/A
Next qtr.1.40%N/AN/AN/A
Current year5.00%N/AN/AN/A
Next year-5.80%N/AN/AN/A
Next 5 years (per annum)30.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A